1102PRESULTS OF THE EXTENSION TRIAL OF OPTIM, A...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

1102PRESULTS OF THE EXTENSION TRIAL OF OPTIM, A MULTICENTER, RANDOMIZED PHASE 3 TRIAL OF TALIMOGENE LAHERPAREPVEC (T-VEC) VS GM-CSF FOR UNRESECTED STAGE IIIB-IV MELANOMA

Nemunaitis, J.J., Andtbacka, R.H., Ross, M., Amatruda, T., Chesney, J., Collichio, F.A., Harrington, K.J., Steven, N.M., Fourie, S., Dreosti, L., Li, A., Liu, K., Shilkrut, M., Coffin, R., Kaufman, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu344.18
Date:
September, 2014
File:
PDF, 67 KB
2014
Conversion to is in progress
Conversion to is failed